Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mizuho Maintains Neutral on DCP Midstream, Raises Price Target to $31

Mizuho analyst Gabriel Moreen maintains DCP Midstream (NYSE:DCP) with a Neutral and raises the price target from $28 to $31.

byBenzinga Newsdesk

August 9, 2021

1 minute read

Mizuho analyst Gabriel Moreen maintains DCP Midstream (NYSE:DCP) with a Neutral and raises the price target from $28 to $31.

Did Umbilical Cord Blood Transplant Help Cure A Woman’s HIV infection?

By Vandana Singh

Today, 6:20 AM

A woman in the New York City area appears to have been cured of an HIV infection, Wall Street Journal reported, provid

Dorman Products Q3 Adj. EPS $1.17 Misses $1.21 Estimate, Sales $413.47M Beat $407.54M Estimate

By Bill Haddad

Today, 6:20 AM

Dorman Products (NASDAQ:DORM) reported quarterly earnings of $1.17 per share which missed the analyst consensus estimate of $1.21 by 3.31 percent. This is a 0.85 percent decrease over earnings of $1.18 per share from the

DORM

Keybanc Maintains Overweight on Life Storage, Raises Price Target to $160

By Benzinga Newsdesk

Today, 6:20 AM

Keybanc maintains Life Storage (NYSE:LSI) with a Overweight and raises the price target from $146 to $160.

LSI

Cantor Fitzgerald Downgrades Cutera to Neutral, Lowers Price Target to $33

By Benzinga Newsdesk

Today, 6:20 AM

Cantor Fitzgerald analyst Louise Chen downgrades Cutera (NASDAQ:CUTR) from Overweight to Neutral and lowers the price target from $85 to $33.

CUTR

Mizuho Maintains Neutral on DCP Midstream, Raises Price Target to $31

Related Posts

Did Umbilical Cord Blood Transplant Help Cure A Woman’s HIV infection?

Dorman Products Q3 Adj. EPS $1.17 Misses $1.21 Estimate, Sales $413.47M Beat $407.54M Estimate

Keybanc Maintains Overweight on Life Storage, Raises Price Target to $160

Cantor Fitzgerald Downgrades Cutera to Neutral, Lowers Price Target to $33